Shaokun Shu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Chemotherapy Induced

Gene Expression

Top Venues

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Dong, Xiaoxuan Meng, Tong Zhang, Zhifang Guo, Yaxi Liu, Peihuang Wu, Shiwei Chen, Fanqi Zhou, Yanni Ma, Haiqing Xiong, Shaokun Shu, Aibin He
Single-cell EpiChem jointly measures drug-chromatin binding and multimodal epigenome. Nature methods (2024)
Chao Dong, Xiaoxuan Meng, Tong Zhang, Zhifang Guo, Yaxi Liu, Peihuang Wu, Shiwei Chen, Fanqi Zhou, Yanni Ma, Haiqing Xiong, Shaokun Shu, Aibin He
Single-cell EpiChem jointly measures drug-chromatin binding and multimodal epigenome. Nature methods (2024)
Maša Alečković, Zheqi Li, Ningxuan Zhou, Xintao Qiu, Bethlehem A Lulseged, Pierre Foidart, Xiao-Yun Huang, Kodie Garza, Shaokun Shu, Nikolas Kesten, Rong Li, Klothilda Lim, Ana Christina Garrido-Castro, Jennifer L Guerriero, Jun Qi, Henry W Long, Kornelia Polyak
Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer. Molecular cancer therapeutics (2023)
Laura E Stevens, Guillermo Peluffo, Xintao Qiu, Daniel Temko, Anne Fassl, Zheqi Li, Anne Trinh, Marco Seehawer, Bojana Jovanovic, Maša Alečković, Callahan M Wilde, Renee C Geck, Shaokun Shu, Natalie L Kingston, Nicholas W Harper, Vanessa Almendro, Alanna L Pyke, Shawn B Egri, Malvina Papanastasiou, M Kendell Clement, Ningxuan Zhou, Sarah R Walker, Jacqueline Salas, So Yeon Park, David A Frank, Alexander Meissner, Jacob D Jaffe, Piotr Sicinski, Alex Toker, Franziska Michor, Henry W Long, Beth A Overmoyer, Kornelia Polyak
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states. Cancer research (2022)